IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v477y2011i7364d10.1038_nature10380.html
   My bibliography  Save this article

Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection

Author

Listed:
  • Marceline Côté

    (Brigham and Women’s Hospital)

  • John Misasi

    (Brigham and Women’s Hospital
    Children’s Hospital)

  • Tao Ren

    (New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Harvard Medical School)

  • Anna Bruchez

    (Brigham and Women’s Hospital)

  • Kyungae Lee

    (New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Harvard Medical School)

  • Claire Marie Filone

    (Brigham and Women’s Hospital
    United States Army Medical Research Institute of Infectious Diseases)

  • Lisa Hensley

    (United States Army Medical Research Institute of Infectious Diseases)

  • Qi Li

    (Brigham and Women’s Hospital)

  • Daniel Ory

    (Diabetic Cardiovascular Disease Center, Washington University School of Medicine)

  • Kartik Chandran

    (Brigham and Women’s Hospital
    Present address: Department of Microbiology and Immunobiology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.)

  • James Cunningham

    (Brigham and Women’s Hospital
    Harvard Medical School)

Abstract

Filovirus infectivity factors The extraordinary virulence of the Ebola and Marburg filoviruses has spurred intensive research into the molecular mechanisms by which they multiply and cause disease. Carette et al. use a genome-wide genetic screen in human cells to identify factors required for entry of Ebola virus. The screen uncovered 67 mutations disrupting all six members of the homotypic fusion and vacuole protein-sorting (HOPS) multisubunit tethering complex, which is involved in the fusion of endosomes to lysosomes, and 39 independent mutations that disrupt the endo/lysosomal cholesterol transporter protein Niemann–Pick C1 (NPC1). Côté et al. report the identification of a novel benzylpiperazine adamantane diamide-derived compound that inhibits EboV infection in cell culture, with NPC1 being the target. The unexpected role for the hereditary disease gene NPC1 in Ebola virus infection may facilitate the development of antifilovirus therapeutics.

Suggested Citation

  • Marceline Côté & John Misasi & Tao Ren & Anna Bruchez & Kyungae Lee & Claire Marie Filone & Lisa Hensley & Qi Li & Daniel Ory & Kartik Chandran & James Cunningham, 2011. "Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection," Nature, Nature, vol. 477(7364), pages 344-348, September.
  • Handle: RePEc:nat:nature:v:477:y:2011:i:7364:d:10.1038_nature10380
    DOI: 10.1038/nature10380
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature10380
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature10380?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Massimo Florio & Simona Gamba, 2021. "Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 387-409, September.
    2. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    3. Vanessa Monteil & Hyesoo Kwon & Lijo John & Cristiano Salata & Gustav Jonsson & Sabine U. Vorrink & Sofia Appelberg & Sonia Youhanna & Matheus Dyczynski & Alexandra Leopoldi & Nicole Leeb & Jennifer V, 2023. "Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    4. Ilyas Khan & Sunan Li & Lihong Tao & Chong Wang & Bowei Ye & Huiyu Li & Xiaoyang Liu & Iqbal Ahmad & Wenqiang Su & Gongxun Zhong & Zhiyuan Wen & Jinliang Wang & Rong-Hong Hua & Ao Ma & Jie Liang & Xia, 2024. "Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1," Nature Communications, Nature, vol. 15(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:477:y:2011:i:7364:d:10.1038_nature10380. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.